JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 48 filers reported holding JANUX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,942,265 | -12.6% | 192,685 | +2.9% | 0.00% | – |
| Q2 2023 | $2,223,132 | +31.3% | 187,290 | +33.8% | 0.00% | – |
| Q1 2023 | $1,693,650 | -8.0% | 139,971 | +0.2% | 0.00% | – |
| Q4 2022 | $1,840,218 | -0.4% | 139,728 | +2.5% | 0.00% | – |
| Q3 2022 | $1,847,000 | +13.7% | 136,364 | +2.4% | 0.00% | – |
| Q2 2022 | $1,625,000 | -19.2% | 133,157 | -5.1% | 0.00% | – |
| Q1 2022 | $2,011,000 | -11.8% | 140,247 | +21.4% | 0.00% | – |
| Q4 2021 | $2,279,000 | -9.9% | 115,495 | -1.3% | 0.00% | – |
| Q3 2021 | $2,530,000 | – | 116,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |